AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Svitinib 12.5 Capsule

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Sunitinib (12.5mg)

Overview Svitinib 12.5 Capsule

Svitinib 12.5mg capsules are prescribed for kidney cancer and gastrointestinal stromal tumors. Its mechanism involves inhibiting enzymes crucial for cancer cell proliferation, resulting in tumor shrinkage and growth retardation. This medication may be ingested with or without food, but consistent daily timing maximizes efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere strictly to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for several weeks or months; discontinue only under medical supervision. Frequent side effects include fatigue, diarrhea, nausea, emesis, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring is often recommended. Svitinib can lower blood glucose, potentially causing hypoglycemic episodes (including fainting); diabetics should monitor blood sugar closely and discuss potential adjustments to their diabetes medication. Inform your physician of pre-existing heart, liver, kidney, or bleeding disorders before commencing treatment. Drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation; reliable contraception for both partners is essential throughout the treatment period.

Primary Ingredients of Svitinib 12.5 Capsule

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Svitinib 12.5 Capsule

Kidney and gastrointestinal stromal tumor therapies

Major Benefits of Svitinib 12.5 Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Svitinib 12.5mg Capsules. These capsules can be administered with or without food, however, consistent timing is recommended.

Common Side effects of Svitinib 12.5 Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Svitinib 12.5 Capsule:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Svitinib 12.5mg capsules can be administered with or without food; however, consistent timing is recommended.

How Svitinib 12.5 Capsule works:

Svitinib 12.5mg capsules are an anticancer drug that inhibits the action of specific tyrosine kinase proteins on cell surfaces, thereby halting cancer cell multiplication. The medication further limits the development of tumor blood supply, thus preventing the spread of malignant neoplasms.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Svitinib 12.5 Capsule and alcohol consumption: The safety of combining these is unestablished. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Svitinib 12.5 Capsule during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Svitinib 12.5 Capsule while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Svitinib 12.5 Capsules might lead to adverse reactions impacting driving ability. Dizziness is a potential side effect. Refrain from driving or operating machinery if dizziness occurs during treatment.

KidneyKidneySAFE IF PRESCRIBED

Svitinib 12.5 mg capsules can be administered to patients with renal impairment without modification of the prescribed dosage.

LiverLiverSAFE IF PRESCRIBED

Svitinib 12.5 mg capsules can be administered safely to individuals with hepatic impairment. No alteration of the Svitinib 12.5 mg capsule dosage is necessary.

What if you forget to take Svitinib 12.5 Capsule :

Omit any missed Svitinib 12.5 Capsule dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Svitinib 12.5 Capsule

LabelValue
Chemical Type Indole and Pyrrole Derivatives
Developing Habits No.
Treatment Category Cancer Treatments

FAQs on Svitinib 12.5 Capsule

Follow your doctor's instructions precisely when taking Svitinib 12.5 Capsule. This medication should be initiated only by physicians experienced in cancer treatment. Take one capsule daily, with or without food. Avoid grapefruit juice and grapefruit while using Svitinib 12.5 Capsule to minimize potential side effects.
Svitinib 12.5 Capsule may cause skin lightening and hair loss. You may also experience dry, thickened, or cracked skin, blisters, or rashes on your palms and soles. While these side effects usually disappear after stopping treatment, serious, potentially fatal skin reactions like severe rash or rapidly spreading skin ulcers can occur. Report any signs of skin infection (fever, pain, redness, swelling, pus, or bleeding) to your doctor immediately.
Svitinib 12.5 Capsule may cause life-threatening liver damage. Report itching, yellowing of eyes or skin, dark urine, or right upper abdominal pain or discomfort immediately. Your doctor will monitor your liver function with blood tests before and throughout treatment. Treatment may be temporarily or permanently discontinued if liver problems develop.
Svitinib 12.5 Capsule has no generic equivalent. It works by inhibiting protein kinase, an enzyme on cancer cells that drives their growth and spread. This blockage prevents cancer progression. Other protein kinase inhibitors include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
Svitinib 12.5 Capsule lacks supporting research for concurrent use with other chemotherapy drugs. It's employed in gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, specifically when imatinib, another anticancer medication, proves ineffective or is unsuitable for the patient.
Svitinib 12.5 Capsule can lower blood sugar. Diabetic patients should monitor their blood sugar closely as it may drop dangerously low, potentially causing unconsciousness. Your anti-diabetic medication dosage may require adjustment based on these blood sugar readings.
Sunitinib 12.5mg capsules can raise blood pressure. Regular blood pressure monitoring is essential. Report severe headache, dizziness, lightheadedness, or vision changes to your doctor immediately. They may prescribe medication to manage high blood pressure or temporarily suspend treatment.
Svitinib 12.5 Capsule
475
MRP 550
13% off